Australia markets closed

Jasper Therapeutics, Inc. (JSPRW)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1485+0.0087 (+6.22%)
As of 10:00AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
51,785
51,785
34,627
25,421
15,883
Selling general and administrative
17,076
17,076
16,569
11,412
4,800
Total operating expenses
68,861
68,861
51,196
36,833
20,683
Operating income or loss
-68,861
-68,861
-51,196
-36,833
-20,683
Total other income/expenses net
-803
-803
12,810
6,196
-10,986
Income before tax
-64,465
-64,465
-37,685
-30,637
-31,669
Income from continuing operations
-64,465
-64,465
-37,685
-30,637
-31,669
Net income
-64,465
-64,465
-37,685
-30,637
-31,669
Net income available to common shareholders
-64,465
-64,465
-37,685
-30,637
-31,669